Skip to Content

News Releases

News Releases

Date Title and Summary
Toggle Summary BioScrip Reports Fourth Quarter and Full Year 2018 Financial Results
DENVER , March 15, 2019 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced its fourth quarter and full year 2018 financial results.                               
Toggle Summary Home and Alternate Site Infusion Therapy Providers BioScrip and Option Care to Merge
Creates a Leading Independent Provider of Home and Alternate Site Infusion Services with  Deep Clinical Expertise and Broad Therapy Portfolio Enhanced Scale and Improved Financial Profile Expected to Enable Growth in Attractive and Growing Segment of U.S.
Toggle Summary BioScrip Reschedules Release of Fourth Quarter and Full Year 2018 Financial Results and Conference Call
DENVER , March 13, 2019 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that the Company has rescheduled the release of its fourth quarter and full year 2018
Toggle Summary BioScrip Schedules Release of Fourth Quarter and Full Year 2018 Financial Results and Conference Call
DENVER , Feb. 25, 2019 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that the Company will issue its financial results press release for the fourth quarter
Toggle Summary BioScrip to Present at the 37th Annual J.P. Morgan Healthcare Conference
DENVER , Jan. 03, 2019 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that Daniel E. Greenleaf , President and Chief Executive Officer, will present at the
Toggle Summary BioScrip to Host Analyst and Investor Day
DENVER , Nov. 26, 2018 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that the Company will host an Analyst and Investor Day on Thursday, December 6, 2018 in
Toggle Summary BioScrip to Present at the Bank of America Merrill Lynch 2018 Leveraged Finance Conference
DENVER , Nov. 20, 2018 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that Daniel E. Greenleaf , President and Chief Executive Officer, and Stephen M.
Toggle Summary BioScrip Reports Third Quarter 2018 Financial Results
DENVER , Nov. 06, 2018 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced its third quarter 2018 financial results.                                               
Toggle Summary BioScrip Comments on Implementation of Medicare Home Infusion Transition Benefit
-- Reaffirming Guidance for 2019 Adjusted EBITDA of at least $75 million -- DENVER , Nov. 01, 2018 (GLOBE NEWSWIRE) --   BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that the
Toggle Summary BioScrip to Present at the 2018 Stephens NY Investment Conference
DENVER , Oct. 25, 2018 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that Stephen M. Deitsch , Senior Vice President, Chief Financial Officer and Treasurer,